. Data science for mental health: a UK perspective on a global challenge. The Lancet Psychiatry, 3(10), 993-998. http://dx.doi.org/10.1016/S2215-0366(16)30089-X _____________________________________________________________ This item is brought to you by Swansea University. Any person downloading material is agreeing to abide by the terms of the repository licence. Copies of full text items may be used or reproduced in any format or medium, without prior permission for personal research or study, educational or non-commercial purposes only. The copyright for any work remains with the original author unless otherwise specified. The full-text must not be sold in any format or medium without the formal permission of the copyright holder.
WHAT IS DATA SCIENCE?
Data science is the extraction of knowledge from high-volume data, using skills in computing science, statistics and the specialist domain knowledge of experts. 1 Data science pervades global business and modern living and can partner technical revolutions, such as medical genomics and imaging, to revolutionise the monitoring, diagnosis, treatment and prevention of disease. This ideal of interdisciplinary, evidence-based, data-driven precision medicine is implicit in the research strategies of major funding organisations. The case for data science is often made for cancer, heart and infectious diseases and yet, mental disorders rarely feature as first line targets. Here we argue that it is time to recognise the enormous potential for data science to transform mental health research and clinical practice. 
WHY MENTAL HEALTH AND WHY NOW?
Mental disorders are arguably the greatest 'hidden' burden of ill health, with substantial long-term impacts on individuals, carers and society. 2 People with these conditions are often socially excluded 3 and less likely to participate in research studies or adhere to follow up. [4] [5] [6] Complexities around defining diagnoses present challenges for research into mental health conditions and thus enhanced longitudinal datasets are needed to supplement observational research. Data science offers an unprecedented opportunity not only for more robust diagnostics, but also the prediction of outcome, treatment response, and patient preferences to inform interventions. 7 It may also provide more effective targeting of recruitment to observational and interventional studies. Such data are large in size and dimensions and require the application of analytical techniques, such as machine learning, where more conventional techniques are less computationally tractable.
A key issue in data science is the description of data types that are the most informative, most readily available and most easily and efficiently captured.
Generic data types include electronic health and prescribing records, education, welfare, socio-demographic, laboratory and real world monitoring through wearable devices and environmental sensors. More specific data might include genomic data, in vivo brain imaging and cognitive/behavioural/psychological traits. Important challenges should be recognised, which include shortcomings in dataset completeness and linkage potential, as well as acceptability to patients and the wider public, given the perceived sensitivity of mental health data. It is also important to consider the types of information that can, in the round, create new ways of classifying mental health and illness.
WHAT RESOURCES DO WE HAVE IN THE UK?
Within the UK we have rich resources for data science in mental health. In this rapidly moving field, we have selected a few exemplars for data science in the UK. Whilst these examples give an indication of the range of current resources, they also provide a template from which to shape the profile of data science for mental health in future years. Whole-genome data is also available, and serum and urinary proteomics studies are under development. All participants were screened for lifetime depression:
Population cohorts
2,706 participants (13.5%) met the DSM IV criteria for major depressive disorder (MDD).
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Participants are currently being re-contacted for questionnaire-based assessment and further clinical and brain imaging measures.
Domain specific cohorts linked to routinely collected data (NCMH and SAIL Databank)
In contrast to population based research cohorts, several UK resources are focussed specifically on Mental Health and routinely collected clinical data from the NHS, the UK's comprehensive healthcare provider. These data may be more representative of the general population and provide a framework for implementation.
NCMH and SAIL Databank
The National Centre NCMH has subsequently developed a research platform and infrastructure for mental health research in Wales. The NCMH cohort can now be linked to routine data nested within prevalent diagnostic cohorts. These cohorts can be tracked across healthcare settings, whilst protecting privacy, through linkage to routine electronic health and social datasets from the Secure Anonymised Information Linkage (SAIL) databank (www.saildatabank.com).
12,13
The SAIL databank is a research data repository for Wales, holding over 2Bn
anonymised health records from ~3.5M patients. Primary care data include demographics, diagnoses, symptoms, referrals, laboratory investigations and prescriptions. Linkage to the hospital inpatient database provides information on admissions, diagnoses, surgery, treatment and discharges. Coverage of outpatient appointments, emergency attendances, child health, educational attainment, cause-specific mortality, deprivation and urbanicity are also recorded. Use of data is conducted in accordance with data protection and information governance legislation using a split file approach.
12,13
Electronic health record derived cohorts and the Farr Institute
The increasing use of electronic health records is creating databases unparalleled both in sample size and in the depth of information contained. The use of these data for research is encouraged by policy 14,15 subject to technical and ethical considerations.
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An important distinction is made between structured information and unstructured text -the former being simpler to analyse, albeit that clinical uncertainties are often poorly coded. [22] [23] [24] [25] [26] Here, text mining may need to be employed alongside structured information to better define groups. only the data structuring and de-identification pipeline afforded by CRIS itself, but also the wider data security and governance model which has been patientled from the outset. 36 Research applications have included searches to help identify and characterise rare scenarios for further investigation, 37, 38 and data linkage projects to characterise physical health outcomes. 39, 40 Recent enhancements include the development of natural language processing applications to derive structured information from the text fields present in the electronic mental health record. These include recorded diagnoses, cognitive test scores, pharmacotherapy and symptom profiles. There is an initiative supported by the Department of Health to support closer data linkage between these datasets in future. 47 The CORC approach is an example of both the opportunities and the challenges in collecting and using routinely collected data from mental health service providers, and the use of 'deep domain knowledge'. CORC is committed to use of the data to inform "Precision Mental Health" 48 whilst also being mindful of the complexities, limitations and flaws in the data. 49 CORC draws on this data to support clinical decision-making, performance management, quality improvement and specific research studies.
Linkage to 'real-time' health data and wearable devices
The increasing use of wearable devices, such as activity monitors, smartphones and watches has provided a vast new source of health data. One of the main advantages is the rapid availability of 'real-time' data (e.g. steps and sleep patterns), which can include contemporaneous measures of heart rate, mood, diet, sleep and biochemistry. Access to personally generated data can be Patients4Data (patients4data.co.uk). These campaigns engage with the public and policymakers to promote the power of patient data and influence regulatory authorities to allow continuing use of data for patient and public benefit. These initiatives have the potential to shape research questions and ensure these are meaningful for communities and patient groups, and will help to ensure sustainability. Such activity also sets the work within a wider public context and will improve visibility, transparency, and acceptability.
Health data are personal and sensitive, and attitudes research suggests that mental health data are among the most sensitive. 50 , 51 Existing initiatives demonstrate that substantive patient involvement from the start (in the design, implementation, use and development of data-sharing initiatives), can help to ensure that meaningful progress is made. 35 It is important to attend to the growing body of research that helps us to understand the diverse reasons why people might be reluctant or unwilling to consent to the use of their data for mental health research. 52, 53 Studies indicate, encouragingly, that a majority of mental health service users agree to the use of their health records for research -particularly when efforts to engage in on-going communication about their use and potential benefits are made. 35, 54 There may be lessons to be learned from cancer research, which has been transformed from being characterised by stigma and under-funding into a highly successful global research movement.
Safe and transparent models of governance for re-use of mental health data are essential for developing and maintaining public trust. Systems have successfully been developed that protect privacy whilst enabling research in the public interest. In the future, innovations that allow the public further control over their data may offer further opportunities, such as dynamic models of consent 55 Consultation work since then suggests that the public is content to offer support for the use of administrative and health data in research, provided there are robust processes to ensure that data security and limited access to trusted personnel conducting research for public benefit. It appears that the public is more supportive of academic and clinical research than work conducted by commercial organisations. 50, 57 All the outputs generated are scrutinised to ensure they do not identify individuals or breach privacy before being released. Plain English summaries of research are published online and open access publication is a condition of all research. Support to researchers throughout this process is provided by a 'research coordinator' within an eData Research and Innovation Service. 56 The key elements of the Scottish model are illustrated within Figure 2 .
The role of medical research charities
The role of research charities in the evolution of data access and utilisation is still emerging. Recent activity, led by the Association of Medical Research
Charities has been focused at the national and international level, advocating for clearer statutory guidelines on oversight and accountability for NHS England as well as ensuring access to data for research purposes in European Union Data Protection legislation. As facilitators of a UK-wide discussion of research opportunities and challenges in mental health data science, MQ is working with charities and government to ensure that mental health is represented in critical discussions.
TRAINING, RESOURCE AND CAPACITY IMPLICATIONS

Technological resource
The capacity of data storage and access, and the personnel to collect and analyse data (and financing to maintain these) are rate-limiting steps in the ongoing development of data science. Routinely-collected 'administrative' and health data tend to be centrally financed by government but have limited phenotypic coverage and have, until recently, been used mainly for planning.
More detailed phenotyping is possible in routine clinical data, such as CRIS in London and PsyCIS in Glasgow, 58 and large scale genetic, '-omics' and neuroimaging studies generate huge volumes of data that pose tractable data storage issues. The combination of these datasets is very challenging and requires data harmonisation and for compatibility issues to be addressed.
Databases need to gather and hold data, and enable users to search for and access data of interest to them. Agreements about data sharing and how to facilitate collaboration and innovation are key issues for data scientists. In practice, data generation projects are deciding on a case by case basis what they they will offer to centralised depositories without offering a coordinated solution for how that data will be linked to other sources. Centralised databases can make themselves more attractive to data depositors by offering managed data access and trusted analysis environments. Existing examples, focussed on genetics, include the Global Alliance for Genomics and Health (GA4GH https://genomicsandhealth.org) and RD-Connect (http://rd-connect.eu).
Skills resource
Identifying, training and fostering a generation of clinically-informed data scientists from a wide range of backgrounds must be a top priority. This requires multidisciplinary training programmes, which expose scientists, informaticians and statisticians to commonly used clinical data, diagnoses and treatments, as well as a range of relevant methodological approaches. Data scientists will usually need further postgraduate training in statistics and computational modelling. All trainees will need to be familiar with ethical and regulatory requirements as well as prepared to become familiar with the diverse ways in which health data are recorded and stored. Given the diversity of resources and methodologies, a variety of approaches seems inevitable and desirable.
Particular care and attention to the career structure of data scientists will be needed to nurture early-career researchers and ensure that expensively acquired expertise is not lost after training. A spectrum of skills and disciplines needs to be present in a data science team and its leadership as well as a common understanding of the need for complementary expertise. As data science evolves in fields such as engineering and finance, there will be opportunities to learn from their experience.
National and international collaboration
There is a need to develop and maintain international and interdisciplinary databases and the networks to support their efficient use. working and convening advisory groups with wide representation will help enhance complementarity across projects and data collections.
OUR VISION OF THE FUTURE
Against a backdrop of no fundamentally new pharmacologic treatment in the past 60 years and a progressive pharmaceutical industry withdrawal from mental health Research and Development, an alternative course is essential. Mental health remains the leading area of unmet medical need in the developed world, and is rapidly acquiring the same status in the developing world.
Combining large healthcare and administrative datasets with real-time monitoring, laboratory, genomic and imaging data could achieve a step change in the way healthcare is provided and research is organised. In our opinion, data science will greatly enhance our ability to conduct discovery science, epidemiological studies, personalised medicine and plan services. Without the better understanding of mental health problems that will come with use of Big Data, longer term visions for self-management, better treatments and learning health systems will not be possible. It is thus vital that current initiatives in data science recognise and support this need. Currently, diagnosis depends upon a self-reported check list following DSM and ICD criteria. The patient will normally present in primary care and be diagnosed by a GP. The care pathway recommended may vary from monitoring only, self-help, counselling or drug prescription. Only a minority of patients with a confirmed diagnosis will respond to the initially selected intervention. Severe cases will be referred to secondary care and the process refined, but a significant minority will remain treatment refractive after testing all available therapies. There are currently no robust methods to stratify patients within a given diagnostic category that supports treatment choice or predicts treatment outcome. Counselling is resource limited and costly compared with drug prescription and this influences health practitioner decision making. The figure highlights in bold how data science could provide robust methods to stratify patients within a given diagnostic category that can support treatment choice and predict treatment outcome (disease stratification and precision medicine). The approach builds upon and extends beyond the NIMH Research Domain Criteria (RDoC) principles (http://www.nimh.nih.gov/researchpriorities/rdoc/index.shtml ). Indicative, non-exhaustive data sources are listed as inputs towards refined diagnostic classification, optimal choice of first line treatment, development of better treatments and monitoring of response. Implicit in this refined approach is that a) multiple relevant data types and sources are readily available at low cost, b) advance epidemiological, statistical, and machine learning data analytics can extract the maximally informative variables, c) the chronic and remitting course of mental illnesses highlights the added value of objective longitudinal and real-time data, for input and feedback to patients, practitioners and carers, d) individual personal predictions and carepathway monitoring will benefit from similarity matching within patient cohorts and against population norms.
